ADAM17 and nasopharyngeal carcinoma: ADAM17‐siRNA was used to knockdown the ADAM17 expression in SUNE1 and CNE2 cells to confirm the effect of ADAM17 in NPC cell invasion and migration; qRT‐PCR and Western blot analysis were used for verification (Figure 5D and 5H).